Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Chemical & Pharmaceutical (Holding) Group (CPHG) is a large-scale state-owned enterprise based in Chongqing, China, that integrates the chemical and pharmaceutical industries. The group operates across three primary business segments: pharmaceutical industry, chemical industry, and pharmaceutical commerce. Through its major subsidiaries, such as Chongqing Pharmaceutical (Group) Co., Ltd., CPHG is a leader in drug distribution and healthcare services in Western China. Its manufacturing portfolio includes a wide range of active pharmaceutical ingredients (APIs), chemical drugs, and traditional Chinese medicines. The company maintains high-standard GMP facilities and is a significant contributor to the regional economy and public health infrastructure. CPHG also engages in international trade, exporting chemical and pharmaceutical products to global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Chemical & Pharmaceutical (Holding) Group.